Patents by Inventor David C. Park

David C. Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apparatus and methods of configurable system event and resource arbitration management
    Patent number: 8238911
    Abstract: Methods, apparatus, and computer-readable media for management and arbitration of dedicated mobile communication resources for mobile applications are provided. Mobile applications can be given a priority level that establishes an importance with respect to one or more other mobile applications and at least one mobile resource. If competing applications attempt to access the mobile resource concurrently, access can be provided to an application having higher priority level. Furthermore, control of a resource can be taken away from an application having lower priority in order to affect control of such resource for a higher priority application. In one aspect, a privilege code of an application can be verified prior to establishing control of the resource for the application, to mitigate a likelihood of inappropriate transfer of resources.
    Type: Grant
    Filed: May 27, 2008
    Date of Patent: August 7, 2012
    Assignee: QUALCOMM Incorporated
    Inventors: Tianyu Li D'Amore, Uppinder Singh Babbar, David C. Park, Srinivasan Balasubramanian
  • APPARATUS AND METHODS OF CONFIGURABLE SYSTEM EVENT AND RESOURCE ARBITRATION MANAGEMENT
    Publication number: 20090119773
    Abstract: Methods, apparatus, and computer-readable media for management and arbitration of dedicated mobile communication resources for mobile applications are provided. Mobile applications can be given a priority level that establishes an importance with respect to one or more other mobile applications and at least one mobile resource. If competing applications attempt to access the mobile resource concurrently, access can be provided to an application having higher priority level. Furthermore, control of a resource can be taken away from an application having lower priority in order to affect control of such resource for a higher priority application. In one aspect, a privilege code of an application can be verified prior to establishing control of the resource for the application, to mitigate a likelihood of inappropriate transfer of resources.
    Type: Application
    Filed: May 27, 2008
    Publication date: May 7, 2009
    Inventors: Tianyu Li D'AMORE, Uppinder Singh BABBAR, David C. PARK, Srinivasan BALASUBRAMANIAN
  • Sulfonamides having antiangiogenic and anticancer activity
    Patent number: 7491718
    Abstract: Compounds having methionine aminopeptidase-2 inhibitory (MetAP2) are described. Also described are pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, methods of inhibiting angiogenesis, and methods of treating cancer.
    Type: Grant
    Filed: October 8, 2003
    Date of Patent: February 17, 2009
    Assignee: Abbott Laboratories
    Inventors: Kenneth M. Comess, Scott A. Erickson, Jack Henkin, Douglas M. Kalvin, Megumi Kawai, Ki H. Kim, Nwe Y. BaMaung, Chang Hoon Park, George S. Sheppard, Anil Vasudevan, Jieyi Wang, David M. Barnes, Steve D. Fidanze, Lawrence Kolaczkowski, Robert A. Mantei, David C. Park, William J. Sanders, Jason S. Tedrow, Gary T. Wang
  • Sulfonamides having antiangiogenic and anticancer activity
    Publication number: 20040167128
    Abstract: Compounds having methionine aminopeptidase-2 inhibitory (MetAP2) are described. Also described are pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, methods of inhibiting angiogenesis, and methods of treating cancer.
    Type: Application
    Filed: October 8, 2003
    Publication date: August 26, 2004
    Inventors: Kenneth M. Comess, Scott A. Erickson, Jack Henkin, Douglas M. Kalvin, Megumi Kawai, Ki H. Kim, Nwe Y. BaMaung, Chang Hoon Park, George S. Sheppard, Anil Vasudevan, Jieyi Wang, David M. Barnes, Steve D. Fidanze, Lawrence Kolaczkowski, Robert A. Mantei, David C. Park, William J. Sanders, Jason S. Tedrow, Gary T. Wang
  • Sulfonamides having antiangiogenic and anticancer activity
    Publication number: 20040157836
    Abstract: Compounds having methionine aminopeptidase-2 inhibitory (MetAP2) are described. Also described are pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, methods of inhibiting angiogenesis, and methods of treating cancer.
    Type: Application
    Filed: September 23, 2003
    Publication date: August 12, 2004
    Inventors: Kenneth M. Comess, Scott A. Erickson, Jack Henkin, Douglas M. Kalvin, Megumi Kawai, Ki H. Kim, Nwe Y. BaMaung, Chang Hoon Park, George S. Sheppard, Anil Vasudevan, Jieyi Wang, David M. Barnes, Steve D. Fidanze, Lawrence Kolaczkowski, Robert A. Mantei, David C. Park, William J. Sanders, Jason S. Tedrow, Gary T. Wang
  • Substituted pyridines having antiangiogenic activity
    Publication number: 20040014744
    Abstract: Compounds having the formula 1
    Type: Application
    Filed: March 12, 2003
    Publication date: January 22, 2004
    Inventors: Fortuna Haviv, Michael F. Bradley, Jack Henkin, Jurgen Dinges, Daryl R. Sauer, Lawrence Kolaczkowski, Anil Vasudevan, David C. Park